News and Announcements
Jetpack Aviation Launches First Civilian Flight
- Published March 14, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
JetPack Aviation, the company that stunned the engineering and aviation communities with its first public jetpack flight around the Statue of Liberty in 2015. The Company has entered into a development Agreement with Georgia Tech to design and build a Soldier Vertical Mobility System (SVMS) for military application.
KEY TAKEAWAYS:
- JPA, which is currently working with the US Navy under a Cooperative Research and Development Agreement (CRADA).
- Georgia Tech will add advanced electronic subsystems for the new SVMS.
- JetPack Aviation senior staff recently hosted Georgia Tech team members at their headquarters in Van Nuys.
After successful public demonstrations in New York, Los Angeles, London, and Monaco, the JetPack Aviation team has begun an intensive development program towards extending their jetpack’s thrust and flight duration, as well as moving towards an all-electric version.
Court Bivens and Michael Mayo of the ATAS lab at GTRI have been leading the project and coordinating the integration of all subsystems into the SVMS.
The joint SVMS team hopes to move forward by soliciting R&D funds from the U.S. military. Additional funding would enable Georgia Tech and JetPack Aviation to fully integrate the described subsystems into an SVMS and tackle issues such as survivability and reliability, electrical and mechanical infrastructure, and human factor disciplines.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
